Before reading the job post, we encourage you to watch this video about our company. It gives you an inside look at how we started, the team and culture that made us successful, and where we're going. It's easy to read a job post and apply, but people often wonder about the culture and whether they would fit in. If you want to call Harrow your home and genuinely want to be part of a family and something big, then we encourage you to click this link and get to know us.
Who is Harrow?
Harrow (Nasdaq: HROW) is a leading U.S. ophthalmic-focused pharmaceutical company. The Company was founded and continues operating based on the highest corporate values. Members of our Harrow Family often express their pride in being a part of our commitment to (1) innovation, (2) patient access to and affordability of our medicines, and (3) our track record of having never turned down an ophthalmologist doing mission work around the world – providing free medicines in support of mission work aimed at giving or maintaining the gift of sight to those most in need.
At Harrow, we foster our individual and collective entrepreneurial and creative spirits. We focus on pursuing opportunities for drug candidates in underserved markets. We are data-driven and use our access to real-world clinical experience to lower the investment risks of our work. We concentrate on the commercial appeal of high-value assets, and our objective is to seek to make paradigm-shifting medicines available to patients as soon as possible. Our approach to finding high-value opportunities and balancing risk with real-world experience can deliver exceptional value for all our stakeholders.
Harrow’s ophthalmic pharmaceutical portfolio is one of the most comprehensive in the industry, including:
- IHEEZO:
- A broad Dry Eye Disease product line, led by VEVYE® and bolstered by well-known adjacent ocular surface disease products such as FLAREX® and TOBRADEX® ST;
- TRIESENCE®:
- A Specialty Anterior Segment product line, which includes various high-need and utility products such as ILEVRO®, NEVANAC®, and VERKAZIA®;
- ImprimisRx is the nation’s leading ophthalmology-focused compound pharmacy, including an FDA-registered and FDA-inspected 503B outsourcing facility and a 50-state mail-order pharmacy. The division of Harrow serves as an innovation hub and plays a vital role in Harrow’s mission to help patients maintain their gift of sight.
Job Summary
The Vice President of Investor Relations & Communications will work directly with the CEO and CFO and other senior company executives within Harrow to develop and implement Harrow’s Investor Relations and communications strategy. The position will be responsible for managing external communications, assuring effective, compelling, and consistent communication with current and prospective shareholders, financial analysts who are covering and who may cover Harrow, plus other relevant audiences. This position will serve as the company contact and media spokesperson and will oversee all related programs. The position will also be responsible for communicating the Harrow story by articulating the company strategy and progress through press releases, representation and presentations at industry and financial conferences, the development of company materials such as investor presentations and other communication devices, and will manage the content of Harrow’s corporate websites and social media persona. The VP of Investor Relations & Communications will also regularly provide counsel, insights and updates to senior management and the Board regarding investor sentiment, ownership composition, investor targeting, trading dynamics, valuation relative to peers and other IR-related matters. At times, the position may also require involvement in communicating with other companies and third parties supporting in-licensing, out‑licensing or partnering efforts for HROW. Stellar communication and analytical skills are necessary, as well as relevant experience in the pharmaceutical industry. Experience managing investor communications, creating public company investor content, and other corporate external communications, as well as writing and content creation skills, are essential.
Core Responsibilities
Serve as HROW’s primary liaison to the investment community, exhibiting proficiency in communicating the company’s strategy, growth opportunities, competitive position, financial performance, and other investment merits.
- Establish and maintain positive, productive relations with institutional investors, key retail investors, and buy/sell side analysts.
- Serve as the main point of contact for media.
- Develop, implement, and manage strategic investor and public relations plans and manage agencies' activities (IR, PR, etc.) working on behalf of HROW.
- Anticipate opportunities to communicate rather than react to external foreseeable events.
- Develop press releases, Q&A documents, messaging, and other relevant materials to support public disclosures.
- Work collaboratively with senior leadership to develop key messaging and communication materials for investor and analyst conferences, presentations, road shows, earnings releases and other announcements.
- Manage HROW's corporate communications via the Harrow corporate website and social media channels. Update and continuously improve the website and social media efforts ensuring that key messages and communications are consistent messaging across all platforms.
- Work closely with legal counsel and others to ensure that all company communications comply with Reg FD and other relevant rules and regulations.
- Provide counsel and input to the CEO and others to optimize the company’s ongoing interactions with the investment community.
- Regularly conduct financial and data analysis to compare the company’s results and guidance against consensus and individual analyst’s projections, to track valuation and other metrics against peers, to evaluate the competitive landscape and provide other market intelligence to senior management.
- Identify and engage target prospective institutional investors with investment focus aligned with HROW’s investment attributes and strengths.
- Represent HROW at financial and industry conferences and medical meetings, including coordinating meeting schedules and participating in one-on-one meetings with investors.
- Serve as key point of corporate communications to internal employees.
- Perform duties in accordance with established company procedures and policies; perform other duties as assigned.
- Manage earning calls and other conference calls, investor events, annual shareholder meetings, and management roadshows
Qualifications & Requirements
- BA or BS required, MBA and/or CFA charter holder preferred.
- 10+ years of experience working for a public company, preferably life science, including experience in investor and/or public relations, corporate strategy, equity research, investment banking, finance or corporate communications.
- Stellar verbal and written communication skills, including impeccable presentation skills; proven ability to effectively interact with and present to (verbally and in writing) external and internal stakeholders, demonstrated through a personable and energetic communication style with the ability to convey credibility
- Successful track record of interfacing with the investment community and media.
- Understands industry trends.
- Uncompromising ability to maintain confidentiality, exercise sound judgment and the highest level of discretion; knowledge of SEC and disclosure requirements preferred.
- Strong working knowledge of financial modeling techniques and modeling methods used by investors and analysts.
- Excellent organization and time-management skills required. Must be able to manage substantial workload and aggressive timelines in a timely manner, prioritize and work under pressure.
- Strong working knowledge of Reg FD and SEC rules and regulations concerning investment community
- Ability to demonstrate initiative and simultaneously achieve multiple tasks.
Position Type
- On-Site -Nashville
Travel
- Up to 20%
What We Do
Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market.
Our mission as a growing leader in the ophthalmic healthcare market is driven by two core values: (1) unyielding dedication to innovation and (2) a mission of providing affordable and accessible medications. We pride ourselves on closely listening to the needs of providers and their patients, so we can do everything in our power to address them with high-quality products and services.
Our worthwhile mission is producing amazing financial results, and because we’ve produced a 72% compound annual growth rate for our first eight years in business, we are one of the fastest-growing ophthalmic pharmaceutical companies in the United States.
